Avenue Therapeutics Inc.
(ATXI)
undefined
undefined%
At close: undefined
1.80
1.12%
After-hours Dec 13, 2024, 03:59 PM EST
Avenue Therapeutics Inc. Forcast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for ATXI stock have an median target of 56.25, with a low estimate of 56.25 and a high estimate of 56.25. The median target predicts an increase of 3060.11% from the current stock price of 1.78.
Analyst Consensus: Buy
AI Analyst Report
According to 1 stock analyst, the rating for Avenue Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
190.70M
from 0
Increased by -%
Revenue Next Year
258.96M
from 190.70M
Increased by 35.8%
EPS This Year
-6.36
from -73.6
Increased by 91.4%
EPS Next Year
-3.14
from -6.36
Increased by 50.6%